U of T partners with Moderna to advance research in RNA science and technology
Moderna sues Pfizer and BioNTech alleging patent infringement over Covid vaccine
Moderna's Coronavirus Vaccine Nearly 95% Effective, Analysis Finds : Shots - Health News : NPR
FDA expected to authorize Moderna, Pfizer-BioNTech Omicron boosters - POLITICO
FDA Approval Updates: Pfizer, Moderna, and J&J COVID-19 Vaccine - GoodRx
Moderna (MRNA) Says It's Suing Pfizer (PFE), BioNTech Over Covid Shots - Bloomberg
Moderna accuses BioNTech/Pfizer of copying mRNA technology | Financial Times
NIH's Fight for Ownership of Moderna's COVID-19 Patent Highlights Hazards of Business Collaborations
Early Data Show Moderna's Coronavirus Vaccine Is 94.5% Effective - The New York Times
Moderna sues Pfizer and BioNTech, alleges companies violated mRNA patents with COVID vaccines | PBS NewsHour
Moderna on Twitter: "We just announced that the Moderna COVID-19 Vaccine retains neutralizing activity against emerging variants first identified in the U.K. and the Republic of South Africa. Read more: https://t.co/UCCvX0PrKV https://t.co/nCGl3hfhlU" /
Mundo propio Fotografía moderna argentina 1927-1962 Malba
Moderna's Covid-19 vaccine is strongly effective, early look at data show
Moderna booster candidate shows strong response against Omicron subvariants | Reuters
Moderna taps Kenya as site for $500M mRNA manufacturing facility | Fierce Pharma
Protesters at Moderna's Cambridge headquarters call for vaccine patent waivers, expanded global access - The Boston Globe
US opens second COVID boosters to 50 and up, others at risk | AP News
Moderna's COVID-19 vaccine found to be 94.5% effective in recent study | World Economic Forum
Moderna says its new vaccine booster shows 'superior' response to omicron : NPR
Moderna 2-strain booster shows strong subvariant antibody response | CIDRAP
Pioneering mRNA technology - Moderna
Moderna bivalent Covid vaccine appears to work against omicron subvariants BA.4 and BA.5
Gavi signs agreement with Moderna to secure doses on behalf of COVAX Facility | Gavi, the Vaccine Alliance
